CALGARY, Alberta--(BUSINESS WIRE)-- Bayer Crop Science Canada announced the launch of EverGol® Rise, setting a new standard in pulse disease control. Combining four different active ingredients, ...
Bayer has struck a deal to buy Perfuse Therapeutics for $300 million upfront. The buyout, which includes up to $2.15 billion in milestones, will give Bayer control of an eye disease implant that ...
Robust disease profile to control seed- and soil-borne diseases: EverGol Rise provides excellent full-spectrum pathogen control of key diseases in pulse crops. Its four active ingredients provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results